A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

NCT02013830 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Cancer

Interventions

DRUG: bevacizumab [Avastin]
DRUG: capecitabine [Xeloda]

Sponsor

Hoffmann-La Roche